Literature DB >> 9327038

Bronchiectasis in Finland: trends in hospital treatment.

O Säynäjäkangas1, T Keistinen, T Tuuponen, S L Kivelä.   

Abstract

The incidence of bronchiectasis has probably declined in developed countries in recent years, but no reliable statistical data on this are available. The present paper describes the use made of hospital services by bronchiectatic patients in Finland. Data on a total of 12,539 treatment periods for bronchiectasis that had occurred between 1972 and 1992 were collected from the discharge register maintained by the National Research and Development Centre for Welfare and Health (diagnosis 518 in the International Classification of Diseases up to 1986, and 494 from 1987 onwards). The number of admissions, new occurrences of bronchiectasis and days in hospital were calculated by sex and age in relation to the total population at the end of each year. There were 143 and 87 admissions per million inhabitants in 1972 and 1992, respectively. The admissions, new occurrences and the days in hospital all decreased, at annual rates of 1.3, 4.2 and 5.7%, respectively. Thus, where the number of new occurrences was 50 per million persons in 1977, it was 27 per million in 1992. In summary, bronchiectasis-related hospital treatment declined markedly between 1972 and 1992. Trend is attributed to effective treatment of pulmonary infections and the reduction in tuberculosis.

Entities:  

Mesh:

Year:  1997        PMID: 9327038     DOI: 10.1016/s0954-6111(97)90251-1

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  11 in total

Review 1.  [Treatment of not-with cystic fibrosis associated forms bronchiectasis (non-CF bronchiectasis)].

Authors:  J Rademacher; M W Pletz; T Welte
Journal:  Internist (Berl)       Date:  2010-12       Impact factor: 0.743

Review 2.  Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.

Authors:  Annemarie L Lee; Angela T Burge; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2017-09-27

3.  Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006.

Authors:  Amy E Seitz; Kenneth N Olivier; Claudia A Steiner; Ruben Montes de Oca; Steven M Holland; D Rebecca Prevots
Journal:  Chest       Date:  2010-04-30       Impact factor: 9.410

Review 4.  Bronchiectasis in older patients with chronic obstructive pulmonary disease : prevalence, diagnosis and therapeutic management.

Authors:  Deborah Whitters; Robert A Stockley
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

Review 5.  Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.

Authors:  Yong-Hua Gao; Wei-Jie Guan; Gang Xu; Yan Tang; Yang Gao; Zhi-Ya Lin; Zhi-Min Lin; Nan-Shan Zhong; Rong-Chang Chen
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

Review 6.  Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Authors:  Ravishankar Chandrasekaran; Micheál Mac Aogáin; James D Chalmers; Stuart J Elborn; Sanjay H Chotirmall
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

Review 7.  The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.

Authors:  R Masekela; R J Green
Journal:  Mediators Inflamm       Date:  2012-04-18       Impact factor: 4.711

8.  Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends.

Authors:  Felix C Ringshausen; Andrés de Roux; Mathias W Pletz; Nina Hämäläinen; Tobias Welte; Jessica Rademacher
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

9.  Time Trends in Hospital Admissions for Bronchiectasis: Analysis of the Spanish National Hospital Discharge Data (2004 to 2013).

Authors:  Gema Sánchez-Muñoz; Ana López de Andrés; Rodrigo Jiménez-García; Pilar Carrasco-Garrido; Valentín Hernández-Barrera; Fernando Pedraza-Serrano; Luis Puente-Maestu; Javier de Miguel-Díez
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

10.  Evaluation of obstructive sleep apnea in non-cystic fibrosis bronchiectasis: A cross-sectional study.

Authors:  Newton Santos Faria Júnior; Jessica Julioti Urbano; Israel Reis Santos; Anderson Soares Silva; Eduardo Araújo Perez; Ângela Honda Souza; Oliver Augusto Nascimento; José Roberto Jardim; Giuseppe Insalaco; Luis Vicente Franco Oliveira; Roberto Stirbulov
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.